Shares of US clinical-stage biotech Tenaya Therapeutics closed up more than 40% at $0.82 yesterday following its announcement of a potentially lucrative collaboration.

Cambridge, USA-based precision allosteric therapeutics biotech Atavistik Bio has announced the closing of a $40 million ...

Swedish specialty pharma Orexo is reorganizing its management team as it pivots away from direct US commercialization ...

Swiss pharma Roche (ROG: SIX) reported positive Phase II results for its investigational amylin analog petrelintide, showing meaningful weight loss and a placebo-like tolerability profile in people ...

US drugmaker Vertex Pharmaceuticals today announced data from a Phase IV study of Journavx (suzetrigine), a prescription ...

The Accelerating Clinical Trials in the EU (ACT EU) initiative has published a draft guidance document outlining how clinical ...

A pre-clinical biopharmaceutical company dedicated to precision cardiology through targeted RNA therapeutics designed to ...

I've worked with pharmaceutical companies for years, and one pattern keeps repeating: the most significant environmental, health, and safety (EHS) risks are rarely dramatic. They sit in routine ...

Canada based clinical-stage pharma Helus Pharma today announced top-line results from a Phase II signal detection study ...

Swiss drugmaker Roche (ROG: SIX) has released findings from a global survey suggesting that the unpredictability of diabetes ...

Germany’s Merck KGaA reported broadly stable full-year 2025 results, with modest top-line pressure from currency headwinds ...

USA-based Biologos, an ISO 13485–certified and GMP-compliant manufacturer of custom sterile-filtered liquid solutions, today ...